Jorge A Almenara Selected Research

Jorge A Almenara Research Topics

Disease

13	Leukemia 01/2016 - 02/2002
5	Neoplasms (Cancer) 09/2015 - 09/2008
3	Cholangiocarcinoma 12/2014 - 11/2009
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2007 - 07/2003
2	Sinusitis 01/2021 - 01/2018
2	Multiple Myeloma 02/2011 - 09/2008
1	Adenocarcinoma 12/2014
1	Brain Neoplasms (Brain Tumor) 09/2009
1	Glioblastoma (Glioblastoma Multiforme) 09/2009
1	Myeloid Leukemia (Leukemia, Myelocytic) 12/2003
1	Lymphoma (Lymphomas) 07/2003

Drug/Important Bio-Agent (IBA)

11	Histone Deacetylase InhibitorsIBA 01/2016 - 02/2002
5	Histone Deacetylases (Histone Deacetylase)IBA 01/2006 - 07/2003
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2007 - 02/2002
4	alvocidib (flavopiridol)IBA 02/2007 - 02/2002
3	Proteins (Proteins, Gene)FDA Link 12/2014 - 02/2007
3	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2010 - 07/2003
3	Butyric Acid (Butanoic Acid)IBA 01/2006 - 02/2002
2	Biomarkers (Surrogate Marker)IBA 12/2014 - 11/2009
2	sphingosine kinaseIBA 09/2009 - 08/2008
2	LAQ824IBA 01/2006 - 11/2005
2	CaspasesIBA 12/2003 - 07/2003
1	ParaffinIBA 09/2015
1	Formaldehyde (Formol)FDA Link 09/2015
1	NucleotidesIBA 09/2015
1	Cell Surface ReceptorsIBA 12/2014
1	TenascinIBA 12/2014
1	IntegrinsIBA 12/2014
1	Glycoproteins (Glycoprotein)IBA 12/2014
1	PeriostinIBA 12/2014
1	Collagen Type I (Type I Collagen)IBA 12/2014
1	Checkpoint Kinase 1IBA 02/2011
1	7-hydroxystaurosporine (UCN 01)IBA 02/2011
1	Dasatinib (BMS 354825)FDA Link 02/2011
1	ErbB Receptors (EGF Receptor)IBA 09/2010
1	AG-879IBA 09/2010
1	Lapatinib (GW572016)FDA Link 09/2010
1	NF-kappa B (NF-kB)IBA 03/2010
1	SphingolipidsIBA 09/2009
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 09/2009
1	IsoenzymesIBA 09/2009
1	NucleosidesIBA 10/2008
1	fludarabineIBA 10/2008
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2008
1	tipifarnib (R115777)IBA 09/2008
1	Sorafenib (BAY 43-9006)FDA Link 10/2007
1	Messenger RNA (mRNA)IBA 02/2007
1	Vorinostat FDA Link 02/2007
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2006
1	Cytotoxins (Cytolysins)IBA 01/2006
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2006
1	CeramidesIBA 01/2006
1	AcidsIBA 01/2006
1	RoscovitineIBA 11/2005
1	LigandsIBA 12/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2003
1	entinostat (MS 275)IBA 07/2003

Therapy/Procedure

3	Therapeutics 12/2014 - 11/2009
2	Debridement 01/2021 - 01/2018